# 바이오스페이스 일일 뉴스 리포트 - 2025년 05월 15일


## 주요 헤드라인

1. **Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novo-doubles-down-on-oral-obesity-meds-with-septerna-deal-worth-up-to-2-4b>

2. **Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novo-doubles-down-on-oral-obesity-meds-with-septerna-deal-worth-up-to-2-4b>

3. **GSK, iTeos Abandon TIGIT Therapy, Adding to Long List of Recent Class Failures (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/gsk-iteos-abandon-tigit-therapy-adding-to-long-list-of-recent-failures>

4. **Roche Continues US Investments With $550M Diagnostics Push in Lilly’s Backyard (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/roche-continues-us-investments-with-550m-diagnostics-push-in-lillys-backyard>

5. **Trump’s Drug Pricing Policy, Prasad’s CBER Nod, Bayer’s Layoffs and Galapagos’ Next Chapter (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/trumps-drug-pricing-policy-prasads-cber-nod-bayers-layoffs-and-galapagos-next-chapter>

6. **Radiopharma Powerhouses Push Frontiers With New Indications, Innovation (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/radiopharma-powerhouses-push-frontiers-with-new-indications-innovation>

7. **Radiopharma Powerhouses Push Frontiers With New Indications, Innovation (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/radiopharma-powerhouses-push-frontiers-with-new-indications-innovation>


---
*2025년 05월 15일 바이오스페이스 뉴스 피드에서 생성된 리포트*